A more precise understanding of how autoantibodies interact with specific TRIM21 functional domains, and the functional outcomes of these interactions, could enhance the diagnostic specificity and prognostic relevance of anti-Ro52 antibodies in autoimmune diseases. This evidence concerns the gene TRIM21 and autoimmune disease.